How will PARP inhibitors change advanced PCa treatment?

Urology Times asked Maha H. Hussain, MD: How will the advent of PARP inhibitors change the management of advanced prostate cancer? 

For more on PARP inhibitors, see: PARP inhibitor significantly extends rPFS vs. hormonal therapy

More videos:

Focal therapy vs. surveillance for low-risk PCa

Medicare final rule: Changes affect cysto, prostate Bx reimbursement

Stone recurrence: Advice for young urologists